GRASS 2800 BAU — Competitive Intelligence Brief

GRASS 2800 BAU (GRASS 2800 BAU) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Allergen immunotherapy extract. Area: Immunology / Allergy.

marketed Allergen immunotherapy extract Grass pollen allergens (Poa pratensis, Lolium perenne, and other grass species) Immunology / Allergy Small molecule

Target snapshot

GRASS 2800 BAU (GRASS 2800 BAU) — Clinique Spécialisée en Allergies de la Capitale. GRASS 2800 BAU is a grass pollen allergen extract that desensitizes the immune system to grass pollen through repeated exposure, reducing allergic responses.

Comparator set (3 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
GRASS 2800 BAU TARGET	GRASS 2800 BAU	Clinique Spécialisée en Allergies de la Capitale	marketed	Allergen immunotherapy extract	Grass pollen allergens (Poa pratensis, Lolium perenne, and other grass species)
PURETHAL Grasses, 20.000 AUM/ml	PURETHAL Grasses, 20.000 AUM/ml	HAL Allergy	marketed	Allergen immunotherapy extract	Grass pollen allergens (IgE and T-cell epitopes)
PURETHAL Birch, 20.000 AUM/ml	PURETHAL Birch, 20.000 AUM/ml	HAL Allergy	marketed	Allergen immunotherapy extract	Birch pollen allergens (Bet v 1 and related proteins)
Depigoid Parietaria judaica 1000DPP/ml	Depigoid Parietaria judaica 1000DPP/ml	Laboratorios Leti, S.L.	phase 3	Allergen immunotherapy extract

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Allergen immunotherapy extract class)

1. HAL Allergy · 2 drugs in this class
2. Clinique Spécialisée en Allergies de la Capitale · 1 drug in this class
3. Laboratorios Leti, S.L. · 1 drug in this class